Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1996 Dec;64(12):5151–5160. doi: 10.1128/iai.64.12.5151-5160.1996

Effector mechanisms responsible for gamma interferon-mediated host resistance to Legionella pneumophila lung infection: the role of endogenous nitric oxide differs in susceptible and resistant murine hosts.

L Heath 1, C Chrisp 1, G Huffnagle 1, M LeGendre 1, Y Osawa 1, M Hurley 1, C Engleberg 1, J Fantone 1, J Brieland 1
PMCID: PMC174501  PMID: 8945559

Abstract

To facilitate identification of the effector mechanism(s) responsible for gamma interferon (IFN-gamma)-mediated host resistance to Legionella pneumophila, a murine model of legionellosis in BALB/c mice with a targeted disruption in the IFN-gamma gene (gamma knockout [GKO] mice) was developed. Immunocompetent BALB/c mice and GKO mice were inoculated intratracheally with virulent L. pneumophila (10(6) bacteria per mouse), and bacterial clearance and the pulmonary inflammatory response were assessed. L. pneumophila did not replicate in, and was rapidly cleared from, the lungs of immunocompetent BALB/c mice, demonstrating that immunocompetent BALB/c mice are resistant to replicative L. pneumophila pulmonary infections. In contrast, similarly infected GKO mice developed persistent, replicative intrapulmonary L. pneumophila infections with extrapulmonary dissemination of the bacteria to the spleen. Histopathologic and flow cytometric analysis of L. pneumophila-infected lung tissue demonstrated that while immunocompetent BALB/c mice develop multifocal pneumonitis which resolves, similarly infected GKO mice develop diffuse pneumonitis with persistent neutrophil recruitment into the lung. Intratracheal administration of exogenous IFN-gamma to L. pneumophila-infected GKO mice facilitated intrapulmonary clearance of the bacteria, confirming the pivotal role of IFN-gamma in innate host defenses to L. pneumophila lung infection in this murine host. The potential role of endogenous reactive nitrogen intermediates, including nitric oxide (NO), in IFN-gamma-mediated resistance to L. pneumophila pulmonary infections in immunocompetent BALB/c mice was subsequently assessed. Macrophage inducible nitric oxide synthetase (an enzyme responsible for the production of NO) was induced in alveolar cells from L. pneumophila-infected immunocompetent BALB/c mice (with maximal expression at 48 h postinfection) but was not induced in similarly infected GKO mice. However, administration of the NO synthetase inhibitor N-monomethyl-L-arginine did not significantly inhibit clearance of L. pneumophila from the lung of immunocompetent BALB/c mice (compared with that in similarly infected mice not administered N-monomethyl-L-arginine). In contrast, we have previously demonstrated that IFN-gamma-induced host resistance to replicative L. pneumophila lung infections in a susceptible murine host (A/J mice) is mediated, in part, by endogenous NO. Taken together, these studies identify a differing role of endogenous NO in IFN-gamma-mediated resistance to L. pneumophila pulmonary infection in susceptible and resistant murine hosts.

Full Text

The Full Text of this article is available as a PDF (620.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abu Kwaik Y., Eisenstein B. I., Engleberg N. C. Phenotypic modulation by Legionella pneumophila upon infection of macrophages. Infect Immun. 1993 Apr;61(4):1320–1329. doi: 10.1128/iai.61.4.1320-1329.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bhardwaj N., Nash T. W., Horwitz M. A. Interferon-gamma-activated human monocytes inhibit the intracellular multiplication of Legionella pneumophila. J Immunol. 1986 Oct 15;137(8):2662–2669. [PubMed] [Google Scholar]
  3. Blanchard D. K., Djeu J. Y., Klein T. W., Friedman H., Stewart W. E., 2nd Protective effects of tumor necrosis factor in experimental Legionella pneumophila infections of mice via activation of PMN function. J Leukoc Biol. 1988 May;43(5):429–435. doi: 10.1002/jlb.43.5.429. [DOI] [PubMed] [Google Scholar]
  4. Blanchard D. K., Friedman H., Klein T. W., Djeu J. Y. Induction of interferon-gamma and tumor necrosis factor by Legionella pneumophila: augmentation of human neutrophil bactericidal activity. J Leukoc Biol. 1989 Jun;45(6):538–545. doi: 10.1002/jlb.45.6.538. [DOI] [PubMed] [Google Scholar]
  5. Blanchard D. K., Stewart W. E., 2nd, Klein T. W., Friedman H., Djeu J. Y. Cytolytic activity of human peripheral blood leukocytes against Legionella pneumophila-infected monocytes: characterization of the effector cell and augmentation by interleukin 2. J Immunol. 1987 Jul 15;139(2):551–556. [PubMed] [Google Scholar]
  6. Brieland J. K., Remick D. G., Freeman P. T., Hurley M. C., Fantone J. C., Engleberg N. C. In vivo regulation of replicative Legionella pneumophila lung infection by endogenous tumor necrosis factor alpha and nitric oxide. Infect Immun. 1995 Sep;63(9):3253–3258. doi: 10.1128/iai.63.9.3253-3258.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brieland J., Freeman P., Kunkel R., Chrisp C., Hurley M., Fantone J., Engleberg C. Replicative Legionella pneumophila lung infection in intratracheally inoculated A/J mice. A murine model of human Legionnaires' disease. Am J Pathol. 1994 Dec;145(6):1537–1546. [PMC free article] [PubMed] [Google Scholar]
  8. Byrd T. F., Horwitz M. A. Interferon gamma-activated human monocytes downregulate transferrin receptors and inhibit the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. J Clin Invest. 1989 May;83(5):1457–1465. doi: 10.1172/JCI114038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cianciotto N. P., Bangsborg J. M., Eisenstein B. I., Engleberg N. C. Identification of mip-like genes in the genus Legionella. Infect Immun. 1990 Sep;58(9):2912–2918. doi: 10.1128/iai.58.9.2912-2918.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Conlan J. W., Baskerville A., Ashworth L. A. Separation of Legionella pneumophila proteases and purification of a protease which produces lesions like those of Legionnaires' disease in guinea pig lung. J Gen Microbiol. 1986 Jun;132(6):1565–1574. doi: 10.1099/00221287-132-6-1565. [DOI] [PubMed] [Google Scholar]
  11. Conlan J. W., Williams A., Ashworth L. A. In vivo production of a tissue-destructive protease by Legionella pneumophila in the lungs of experimentally infected guinea-pigs. J Gen Microbiol. 1988 Jan;134(1):143–149. doi: 10.1099/00221287-134-1-143. [DOI] [PubMed] [Google Scholar]
  12. Curtis J. L., Huffnagle G. B., Chen G. H., Warnock M. L., Gyetko M. R., McDonald R. A., Scott P. J., Toews G. B. Experimental murine pulmonary cryptococcosis. Differences in pulmonary inflammation and lymphocyte recruitment induced by two encapsulated strains of Cryptococcus neoformans. Lab Invest. 1994 Jul;71(1):113–126. [PubMed] [Google Scholar]
  13. Dalton D. K., Pitts-Meek S., Keshav S., Figari I. S., Bradley A., Stewart T. A. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science. 1993 Mar 19;259(5102):1739–1742. doi: 10.1126/science.8456300. [DOI] [PubMed] [Google Scholar]
  14. Dietrich W. F., Damron D. M., Isberg R. R., Lander E. S., Swanson M. S. Lgn1, a gene that determines susceptibility to Legionella pneumophila, maps to mouse chromosome 13. Genomics. 1995 Apr 10;26(3):443–450. doi: 10.1016/0888-7543(95)80161-e. [DOI] [PubMed] [Google Scholar]
  15. Edelstein P. H. Improved semiselective medium for isolation of Legionella pneumophila from contaminated clinical and environmental specimens. J Clin Microbiol. 1981 Sep;14(3):298–303. doi: 10.1128/jcm.14.3.298-303.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Feeley J. C., Gibson R. J., Gorman G. W., Langford N. C., Rasheed J. K., Mackel D. C., Baine W. B. Charcoal-yeast extract agar: primary isolation medium for Legionella pneumophila. J Clin Microbiol. 1979 Oct;10(4):437–441. doi: 10.1128/jcm.10.4.437-441.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Fujio H., Yoshida S., Miyamoto H., Mitsuyama M., Mizuguchi Y. Investigation of the role of macrophages and endogenous interferon-gamma in natural resistance of mice against Legionella pneumophila infection. FEMS Microbiol Immunol. 1992 Apr;4(4):183–191. doi: 10.1111/j.1574-6968.1992.tb04993.x. [DOI] [PubMed] [Google Scholar]
  18. Gebran S. J., Yamamoto Y., Newton C., Klein T. W., Friedman H. Inhibition of Legionella pneumophila growth by gamma interferon in permissive A/J mouse macrophages: role of reactive oxygen species, nitric oxide, tryptophan, and iron(III). Infect Immun. 1994 Aug;62(8):3197–3205. doi: 10.1128/iai.62.8.3197-3205.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Gebran S. J., Yamamoto Y., Newton C., Tomioka M., Widen R., Klein T. W., Friedman H. LPS inhibits the intracellular growth of Legionella pneumophila in thioglycolate elicited murine peritoneal macrophages by iron-dependent, tryptophan-independent, oxygen-independent, and arginine-independent mechanisms. J Leukoc Biol. 1995 Jan;57(1):80–87. doi: 10.1002/jlb.57.1.80. [DOI] [PubMed] [Google Scholar]
  20. Granger D. L., Hibbs J. B., Jr, Perfect J. R., Durack D. T. Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages. J Clin Invest. 1990 Jan;85(1):264–273. doi: 10.1172/JCI114422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Green S. J., Nacy C. A., Meltzer M. S. Cytokine-induced synthesis of nitrogen oxides in macrophages: a protective host response to Leishmania and other intracellular pathogens. J Leukoc Biol. 1991 Jul;50(1):93–103. doi: 10.1002/jlb.50.1.93. [DOI] [PubMed] [Google Scholar]
  22. Horwitz M. A. Phagocytosis of the Legionnaires' disease bacterium (Legionella pneumophila) occurs by a novel mechanism: engulfment within a pseudopod coil. Cell. 1984 Jan;36(1):27–33. doi: 10.1016/0092-8674(84)90070-9. [DOI] [PubMed] [Google Scholar]
  23. Horwitz M. A., Silverstein S. C. Activated human monocytes inhibit the intracellular multiplication of Legionnaires' disease bacteria. J Exp Med. 1981 Nov 1;154(5):1618–1635. doi: 10.1084/jem.154.5.1618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Horwitz M. A., Silverstein S. C. Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes. J Clin Invest. 1980 Sep;66(3):441–450. doi: 10.1172/JCI109874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Huffnagle G. B., Lipscomb M. F., Lovchik J. A., Hoag K. A., Street N. E. The role of CD4+ and CD8+ T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J Leukoc Biol. 1994 Jan;55(1):35–42. doi: 10.1002/jlb.55.1.35. [DOI] [PubMed] [Google Scholar]
  26. Jensen W. A., Rose R. M., Wasserman A. S., Kalb T. H., Anton K., Remold H. G. In vitro activation of the antibacterial activity of human pulmonary macrophages by recombinant gamma interferon. J Infect Dis. 1987 Mar;155(3):574–577. doi: 10.1093/infdis/155.3.574. [DOI] [PubMed] [Google Scholar]
  27. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  28. Lancaster J. R., Jr, Hibbs J. B., Jr EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages. Proc Natl Acad Sci U S A. 1990 Feb;87(3):1223–1227. doi: 10.1073/pnas.87.3.1223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lander H. M., Sehajpal P., Levine D. M., Novogrodsky A. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J Immunol. 1993 Feb 15;150(4):1509–1516. [PubMed] [Google Scholar]
  30. Matsiota-Bernard P., Léfèbre C., Sedqui M., Cornillet P., Guenounou M. Involvement of tumor necrosis factor alpha in intracellular multiplication of Legionella pneumophila in human monocytes. Infect Immun. 1993 Dec;61(12):4980–4983. doi: 10.1128/iai.61.12.4980-4983.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Mulligan M. S., Ward P. A. Immune complex-induced lung and dermal vascular injury. Differing requirements for tumor necrosis factor-alpha and IL-1. J Immunol. 1992 Jul 1;149(1):331–339. [PubMed] [Google Scholar]
  32. Nash T. W., Libby D. M., Horwitz M. A. IFN-gamma-activated human alveolar macrophages inhibit the intracellular multiplication of Legionella pneumophila. J Immunol. 1988 Jun 1;140(11):3978–3981. [PubMed] [Google Scholar]
  33. Reif D. W., Simmons R. D. Nitric oxide mediates iron release from ferritin. Arch Biochem Biophys. 1990 Dec;283(2):537–541. doi: 10.1016/0003-9861(90)90680-w. [DOI] [PubMed] [Google Scholar]
  34. Seekamp A., Mulligan M. S., Till G. O., Ward P. A. Requirements for neutrophil products and L-arginine in ischemia-reperfusion injury. Am J Pathol. 1993 Apr;142(4):1217–1226. [PMC free article] [PubMed] [Google Scholar]
  35. Simon R. H., McCoy J. P., Jr, Chu A. E., Dehart P. D., Goldstein I. J. Binding of Griffonia simplicifolia I lectin to rat pulmonary alveolar macrophages and its use in purifying type II alveolar epithelial cells. Biochim Biophys Acta. 1986 Jan 23;885(1):34–42. doi: 10.1016/0167-4889(86)90035-2. [DOI] [PubMed] [Google Scholar]
  36. Skerrett S. J., Martin T. R. Intratracheal interferon-gamma augments pulmonary defenses in experimental legionellosis. Am J Respir Crit Care Med. 1994 Jan;149(1):50–58. doi: 10.1164/ajrccm.149.1.8111597. [DOI] [PubMed] [Google Scholar]
  37. Skerrett S. J., Martin T. R. Recombinant murine interferon-gamma reversibly activates rat alveolar macrophages to kill Legionella pneumophila. J Infect Dis. 1992 Dec;166(6):1354–1361. doi: 10.1093/infdis/166.6.1354. [DOI] [PubMed] [Google Scholar]
  38. Skerrett S. J., Schmidt R. A., Martin T. R. Impaired clearance of aerosolized Legionella pneumophila in corticosteroid-treated rats: a model of Legionnaires' disease in the compromised host. J Infect Dis. 1989 Aug;160(2):261–273. doi: 10.1093/infdis/160.2.261. [DOI] [PubMed] [Google Scholar]
  39. Stein-Streilein J., Guffee J. In vivo treatment of mice and hamsters with antibodies to asialo GM1 increases morbidity and mortality to pulmonary influenza infection. J Immunol. 1986 Feb 15;136(4):1435–1441. [PubMed] [Google Scholar]
  40. Summersgill J. T., Powell L. A., Buster B. L., Miller R. D., Ramirez J. A. Killing of Legionella pneumophila by nitric oxide in gamma-interferon-activated macrophages. J Leukoc Biol. 1992 Dec;52(6):625–629. doi: 10.1002/jlb.52.6.625. [DOI] [PubMed] [Google Scholar]
  41. Van Dervort A. L., Yan L., Madara P. J., Cobb J. P., Wesley R. A., Corriveau C. C., Tropea M. M., Danner R. L. Nitric oxide regulates endotoxin-induced TNF-alpha production by human neutrophils. J Immunol. 1994 Apr 15;152(8):4102–4109. [PubMed] [Google Scholar]
  42. Warner R. L., Paine R., 3rd, Christensen P. J., Marletta M. A., Richards M. K., Wilcoxen S. E., Ward P. A. Lung sources and cytokine requirements for in vivo expression of inducible nitric oxide synthase. Am J Respir Cell Mol Biol. 1995 Jun;12(6):649–661. doi: 10.1165/ajrcmb.12.6.7539274. [DOI] [PubMed] [Google Scholar]
  43. Yamamoto Y., Friedman H., Klein T. W. Nitric oxide has an immunoregulatory role other than antimicrobial activity in Legionella pneumophila infected macrophages. Ann N Y Acad Sci. 1994 Aug 15;730:342–344. doi: 10.1111/j.1749-6632.1994.tb44286.x. [DOI] [PubMed] [Google Scholar]
  44. Yamamoto Y., Klein T. W., Newton C. A., Widen R., Friedman H. Differential growth of Legionella pneumophila in guinea pig versus mouse macrophage cultures. Infect Immun. 1987 Jun;55(6):1369–1374. doi: 10.1128/iai.55.6.1369-1374.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Yoshida S., Mizuguchi Y. Multiplication of Legionella pneumophila Philadelphia-1 in cultured peritoneal macrophages and its correlation to susceptibility of animals. Can J Microbiol. 1986 May;32(5):438–442. doi: 10.1139/m86-083. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES